LAS VEGAS, NV – Today, U.S. Senator Jacky Rosen (D-NV), a member of the Senate Committee on Health, Education, Labor and Pensions (HELP) and the Special Committee on Aging, joined a video call with Nevada’s chapters of the Alzheimer’s Association and the Cleveland Clinic Lou Ruvo Center for Brain Health to hear from these organizations on how they are working to treat Alzheimer’s patients amid the pandemic, and about their latest research on Alzheimer’s disease. During the call, the Senator also provided an update on the work she’s doing in Congress to support those facing Alzheimer’s and other neurodegenerative diseases during the COVID-19 pandemic.
“As someone who took care of her aging in-laws and parents, I know first-hand how critical it is that we look out for our nation’s most vulnerable by supporting the thousands of caregivers and medical facilities that are working to provide care to our loved ones during this difficult time,” said Senator Rosen. “As patients and caregivers navigate new obstacles brought on by the coronavirus pandemic, I am encouraged by the incredible work that organizations like the Alzheimer’s Association and the Lou Ruvo Center for Brain Health are doing, and I am committed to making sure that our loved ones receive the care and support they deserve.”
BACKGROUND: Rosen co-sponsored the bipartisan Improving HOPE (Health, Outcomes, Planning, and Education) for Alzheimer’s Act, legislation that would work to increase the utilization of care planning resources among Alzheimer’s patients and caregivers. Rosen also sponsored the Families First Coronavirus Response Act, passed earlier this year, which expanded paid sick leave and leave for workers to care for family members at risk for COVID-19.
Last Congress, then-Congresswoman Rosen co-sponsored the BOLD Infrastructure for Alzheimer’s Act, bipartisan legislation to provide funding to state and public health departments to implement effective interventions to promote early detection and diagnosis and reduce risk. The BOLD Infrastructure for Alzheimer’s Act was signed into law in December 2018.